A versatile ligation-independent cloning method suitable for high-throughput expression screening applicationsNicholas S. Berrow, Raymond J. Owens|Nucleic Acids Research|2007Cited by 571
A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19Jiandong Huo, Raymond J. Owens|Nature Communications|2021Cited by 154
Site-specific attachment to recombinant antibodies via introduced surface cysteine residuesJohn R. Adair, Andrew T. Millican, Nigel Whittle et al.|Protein Engineering Design and Selection|1990Cited by 66
Isotype choice for chimeric antibodies affects binding properties.Maurice M. Morelock, David S. Scher, Robert Rothlein et al.|Journal of Biological Chemistry|1994Cited by 51
From Llama to Nanobody: A Streamlined Workflow for the Generation of Functionalised VHHsLauren Eyssen, Raymond J. Owens|BIO-PROTOCOL|2024Cited by 6